MetaCap

Iris Acquisition II (IRAB) vs Translational Development Acquisition (TDAC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Iris Acquisition II is the larger company by market cap ($229.3 million vs $208.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

IRAB versus TDAC key metrics
MetricIRABTDAC
Share price$10.01$10.82
Market cap$229.28M$208.88M
1-day change0.00%+0.17%
P/E ratio (TTM)—41.61
EPS (TTM)—$0.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.17$10.95
52-week low$9.81$10.35
Distance from 52-week high-1.57%-1.21%
Average volume21.21K27.88K
Shares outstanding17.29M19.31M
SectorFinancial ServicesFinancial Services
IndustryShell CompaniesShell Companies

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Iris Acquisition II

IRAB stock →

Iris Acquisition Corp II does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses.

Financial Services · Shell Companies

About Translational Development Acquisition

TDAC stock →

Translational Development Acquisition Corp. does not have significant operations.

Financial Services · Shell Companies

IRAB vs TDAC FAQ

Which is bigger, Iris Acquisition II or Translational Development Acquisition?

Iris Acquisition II (IRAB) is larger, with a market capitalization of $229.28M compared with $208.88M for Translational Development Acquisition (TDAC).

Are Iris Acquisition II and Translational Development Acquisition in the same industry?

Yes. Both are classified in the Shell Companies industry within the Financial Services sector.

More comparisons